Business Context and Reporting Period
This Form 6-K filing by Belite Bio, Inc. covers the month of August 2025. The report details a registered direct offering of American Depositary Shares (ADSs) and accompanying warrants entered into on August 6, 2025, with an institutional investor.
Key Financial Metrics
- Gross Proceeds: Approximately $15 million.
- Offering Size: 230,770 ADSs and warrants to purchase 230,770 ordinary shares.
- Offering Price: $65.00 per ADS and accompanying warrant.
- Warrant Terms: Immediately exercisable, five-year expiration, exercise price of $65.00 per ADS.
- Expected Closing Date: On or about August 8, 2025.
- Placement Agent: Titan Partners Group LLC (a division of American Capital Partners, LLC).
Material Changes
The filing does not provide comparative financial data (revenue, profit, cash flow, or margins) against prior periods. The primary material change is the execution of the Securities Purchase Agreement for the capital raise described above. Additionally, the Company has agreed to a 30-day lock-up period following the closing, restricting the sale or disposition of ADSs or Ordinary Shares.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on operational outlook, or specific risk factors beyond the standard closing conditions. The transaction is subject to the satisfaction of customary closing conditions. The offering was made pursuant to a shelf registration statement on Form F-3 declared effective on January 27, 2025.
Investor Verification Checklist
- Confirm the actual closing date and receipt of gross proceeds on or about August 8, 2025.
- Review the full text of the Securities Purchase Agreement (Exhibit 1.1) for specific covenants and conditions.
- Verify the impact of the 30-day lock-up period on future share liquidity.
- Check subsequent filings for any changes to the offering terms or closing status.